Font: A | A | A
Early Detection Symposium

Save the Date: Next Canary Foundation Early Detection Symposium:
May 25-27, 2010 in Stanford, California

Canary Foundation Early Detection Symposium serves as a forum for members of the extended Canary Foundation Network to meet and share their successes, challenges, and visions for the field of early detection of cancer. Our goal is to work together to generate and optimize strategies for discovery, validation, and dissemination of tests for early cancer detection.

The speakers and audience include leading academic researchers, clinicians, as well as commercial and foundational partners. Agenda includes keynotes on global, government, and industry perspectives, as well as presentations and posters on Canary's investments towards early detection of ovarian, lung, prostate, and pancreatic cancer.

Invited members of the Canary Foundation Network are encouraged to participate in this unique opportunity to meet and interact with fellow teammates, share ideas and resources, and build new collaborations.


Previous Symposium Speakers

2009

Speaker Affiliation Topic
Don Listwin Canary Foundation Canary Overview & Panel Moderator
Dr. Sylvia Plevritis Stanford University Estimating the Likelihood of Cure from Lung Cancer due to Early Detection
Dr. Peter Bach Memorial Sloan-Kettering Opportunity Window for Early Detection of Lung Cancer
Dr. Joe Gray Lawrence Berkeley Lab The Cancer Genome Atlas
Dr. Greg Heath Illumina Illumina Diagnostics Business: Strategy & Opportunity Knowledge
Dr. Muneesh Tewari Fred Hutchinson Cancer Research Center MicroRNA Biomarker Discovery
Dr. Mark Stolowitz Canary Center at Stanford Technology Panel - Detecting Proteins
Dr. Martin McIntosh Fred Hutchinson Cancer Research Center Technology Panel - Detecting Proteins
Dr. Shan Wang Stanford University Technology Panel - Detecting Proteins
Dr. Rick Gallagher BC Cancer Agency Canadian Partnership for Tomorrow
Dr. Brad Nelson BC Cancer Agency Technology Panel - Creating Antibodies and Assays
Dr. James DeCaprio Dana-Farber Cancer Institute Technology Panel - Creating Antibodies and Assays
Dr. Brian Cao Van Andel Institute Technology Panel - Creating Antibodies and Assays
Dr. James Marks UCSF Helen Diller Family Cancer Center Technology Panel - Creating Antibodies and Assays
Dr. Sam Gambhir Stanford University Canary Molecular Imaging Program
Dr. Ian Thompson University of Texas Prostate Cancer: Biomarkers, Screening and Diagnosis
Dr. Olle Nilsson Fuijreibio Fujirebio: Bringing Markers to Market
Dr. Gregory Rice Baker IDI Multi-marker Diagnostics and Ovarian Cancer
Dr. Martin McIntosh Fred Hutchinson Cancer Research Center Canary Baseline Program
Dr. Charles Drescher Fred Hutchinson Cancer Research Center Canary Ovarian Program
Dr. Samir Hanash Fred Hutchinson Cancer Research Center Canary Lung Program
Dr. Teri Brentnall University of Washington Canary Pancreatic Program
Dr. Peter Nelson Fred Hutchinson Cancer Research Center Canary Prostate Program


2009 Poster Session

2008

Speaker Affiliation Topic
Don Listwin Canary Foundation Canary Overview
Dr. John Niederhuber National Cancer Institute Early Detection and Intervention at NCI
Dr. Lee Hartwell Fred Hutchinson Cancer Research Center Global EDI View
Dr. Ian Jacobs University College of London Ovarian Cancer Screening
Dr. Pat Brown Stanford University Lessons & Gaps in Biomarker Knowledge
Dr. Nicole Urban Fred Hutchinson Cancer Research Center Ovarian Cancer Serum Markers
Dr. Garnet Anderson Fred Hutchinson Cancer Research Center Pre-clinical Biomarkers
Dr. Martin McIntosh Fred Hutchinson Cancer Research Center Biomarker Discovery
Dr. Sam Gambhir Stanford University Molecular Imaging
Dr. Randy Scott Genomic Health Translating Diagnostics
Dr. Martin McIntosh Fred Hutchinson Cancer Research Center Canary Baseline Program
Dr. Charles Drescher Fred Hutchinson Cancer Research Center Canary Ovarian Program
Dr. Sam Hanash Fred Hutchinson Cancer Research Center Canary Lung Program
Dr. Teri Brentnall University of Washington Canary Pancreatic Program
Dr. Pete Nelson Fred Hutchinson Cancer Research Center Canary Prostate Program


2007

Speaker Affiliation Topic
Don Listwin Canary Foundation Canary Foundation Overview
Dr. Chana Palmer Canary Foundation Canary Foundation Resources
Dr. Lee Hartwell Fred Hutchinson Cancer Research Center Early Detection Intervention - A Global View
Dr. Anna Barker National Cancer Institute NCI's Initiatives to Enable Early Detection and Diagnosis of Cancer
Dr. Janet Woodcock Food and Drug Administration FDA's Approach to Molecular Diagnostics
Dr. Sylvia Plevritis Stanford University Modeling Early Detection of Cancer by Screening
Dr. Pat Brown Stanford University A Critical Analysis of Molecular Biomarkers for Early Detection of Cancer
Dr. Dianne Miller British Columbia Cancer Agency The Natural History of Serous Ovarian Cancer
Dr. Chuck Drescher Fred Hutchinson Cancer Research Center Progress in Ovarian Cancer Early Detection Research
Dr. Patricia Shaw University Health Network Precursor Lesions of Serous Carcinoma
Dr. David Huntsman British Columbia Cancer Agency BRCA1 and BRCA2 Ovarian Cancers
Dr. Sam Gambhir Stanford University Molecular Imaging
Dr. Peter Laird University of Southern California DNA Methylation Analysis Technologies
Dr. Martin McIntosh Fred Hutchinson Cancer Research Center Bioinformatics Platform Development and Dissemination
Dr. Brad Nelson British Columbia Cancer Agency Establishing a Platform for Ovarian Cancer Biomarker Evaluation
Dr. Andy Berlin Berlin Science and Technologies A Prototype Magnetic Fallopian Tube Probe
Dr. Leigh Anderson Plasma Proteome Institute Enabling a Protein Biomarker Pipeline Using Targeted Mass Spectrometric Assays for Biomarker Candidates
Dr. Malek Faham Affymetrix Somatic Mutation Detection
Dr. Teri Brentnall University of Washington Pancreatic Cancer Biomarkers
Dr. Pete Nelson University of Washington Prostate Cancer Biomarkers


2006

Speaker Affiliation Topic
Don Listwin Canary Foundation Canary Foundation Overview
Dr. Chana Palmer Canary Foundation Canary Foundation Scientific Programs
Dr. Michael Clarke Stanford University Cancer Stem Cells
Dr. Stephen Quake Stanford University Early Cancer Detection By Counting Molecules
Dr. Pehr Harbury Stanford University Winning the Molecule Lottery
Dr. Sam Gambhir Stanford University Canary Foundation Imaging Project
Dr. Daniela Dinulescu Harvard Medical School Discovery of Ovarian Cancer Biomarkers in Animal Models of Disease
Dr. Sam Hanash Fred Hutchinson Cancer Research Center Proteomics-based Discovery of Cancer Biomarkers in Plasma
Dr. Nicole Urban Fred Hutchinson Cancer Research Center Canary Foundation Ovarian Cancer Early Detection Panel
Dr. Peter Laird University of Southern California Canary Foundation Biomarker Discovery Project
Dr. Henry Rodriguez National Cancer Institute Clinical Proteomic Technologies for Cancer
Dr. Larry Kessler Food and Drug Administration Development of Molecular In Vitro Diagnostics for the Early Detection of Cancer


2005

Speaker Affiliation Topic
Don Listwin Canary Foundation Canary Project Overview
Dr. Anna Barker National Cancer Institute Agency Support
Dr. Lee Hartwell Fred Hutchinson Cancer Research Center The Case for Early Detection
Dr. Nicole Urban Fred Hutchinson Cancer Research Center Canary Fund Case Study: Ovarian Cancer
Dr. Samir Hanash Fred Hutchinson Cancer Research Center Proteomics
Dr. Sam Gambhir Stanford University Molecular Imaging
Dr. Pat Brown Stanford University Transcriptomics
Dr. Peter Laird University of Southern California DNA Based Markers
Dr. Frank McCormick University of San Francisco Impact of Biomarkers on the Future of Cancer Medicine
Dr. George Sawaya University of San Francisco Realizing the Promise: Early Detection of Cancer
Dr. Robert Lipshutz Affymetrix View of Biomarkers in the Industry